Business · 01/11/2002Updated: 10/17/2026 · 1 min read
FDA Postpones Meeting of Women's Health Initiative Subcommittee
Summary
The FDA has postponed the November 12-13, 2002 meeting of the Women's Health Initiative Subcommittee, originally scheduled to discuss reproductive health drugs, due to the need for additional data evaluation by the Center for Drug Evaluation and Research.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →